Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres
Yazarlar (13)
Mehmet Ata Akil Dicle Üniversitesi, Türkiye
Mehmet Zihni Bilik Dicle Üniversitesi, Türkiye
Prof. Dr. Abdulkadir YILDIZ Dicle Üniversitesi, Türkiye
Halit Acet Dicle Üniversitesi, Türkiye
Faruk Ertas Dicle Üniversitesi, Türkiye
Hakki Simsek Van Yüzüncü Yıl Üniversitesi, Türkiye
Nihat Polat Dicle Üniversitesi, Türkiye
Halit Zengin Ondokuz Mayis Üniversitesi, Türkiye
Rabia Akilli Çukurova Üniversitesi, Türkiye
Prof. Dr. Elif Agacayak Dicle Üniversitesi, Türkiye
Fethullah Kayan Dicle Üniversitesi, Türkiye
Mahmut Ozdemir Van Yüzüncü Yıl Üniversitesi, Türkiye
Sait Alan Dicle Üniversitesi, Türkiye
| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Journal of Obstetrics and Gynaecology | ||
| Dergi ISSN | 0144-3615 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 02-2016 |
| Cilt / Sayı / Sayfa | 36 / 5 / 574–580 | DOI | 10.3109/01443615.2015.1107531 |
| Makale Linki | https://www.tandfonline.com/doi/full/10.3109/01443615.2015.1107531 | ||
| Özet |
| We conducted this study to determine demographic details, and clinical presentations in patients with peripartum cardiomyopathy (PPCMP) of Turkish origin. The study population consisted of 58 patients with PPCMP treated at 3 major hospitals in Turkey, retrospectively. In this study, demographic details and initial echocardiographic data were recorded and long-term clinical status was evaluated. The mean age for the patient cohort was 31.47 ± 6.31 years. Thirty-eight patients (73.1%) were multigravida and seven patients had multifetal pregnancy (13.7%). The mean follow-up left ventricular (LV) ejection fraction increased from 31 ± 7 to 38 ± 19. A minority of patients were defined as improvers according to our pre-specified criteria. The average survival period after diagnosis of PPCMP was 20.66 ± 14.44 months. Initial values for LV end-diastolic diameter and urea were higher in the deceased patients compared with the surviving patients, respectively. Twenty-eight (48%) patients with PPCMP showed improvement in the follow-up period. Of the 58 PPCMP patients, 9 (15%) died during a mean follow-up of 32 ± 22 months. |
| Anahtar Kelimeler |
| Heart failure | peripartum cardiomyopathy | pregnancy | systolic dysfunction |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Web of Science | 12 |
| Scopus | 12 |